How The US FDA Honed Remote Tools To Assess Facilities During COVID Inspection Hiatus

 
• By Anju Ghangurde

FDA officials outline the impact of using alternative tools to assess manufacturing facilities amid COVID-19 and share key experiences around these, including with remote interactive evaluations.

FDA office
Alternative Tools Seen As Crucial To Manage Inspection Backlog • Source: Alamy

More from Manufacturing

More from Compliance